Marijuana and IBD: Challenging Decisions
Though patient use of cannabinoids for the treatment of IBD has increased, clinical decision making on whether to formally recommend it as treatment remains difficult.
All articles by Andy Kistler, MD, PharmD
COVID-19: Atypical GI Presentations
There are increasing data to support that many patients with COVID-19 can develop a myriad of gastrointestinal symptoms, which include mild diarrhea, nausea, vomiting and abdominal pain.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...